AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2012:13 ANNUAL REPORT
TABLE OF CONTENTS
Letter of transmittal 3
About this report 4
Message from the CEO 10
Chapter 1: Organisational overview 17
About ASADA 18
Australia’s anti-doping structure 18
Legislative basis 20
Goals 20
Role and functions 20
Outcome and program structure 21
Highlights of 2012–13 22
Chapter 2: Report on performance 25
Program 1.1 — Deterrence, detection and enforcement 26
Deliverables 26
Key Performance indicators 28
Building awareness 30
Communications channels 30
Communication campaigns 31
Media 32
Printed resources 32
Education 34
Partnerships 37
Assisting sporting organisations 39
International engagement 39
Liaison with World Anti-Doping Agency (WADA) 40
Review of the World Anti-Doping Code 40
Review of WADA Prohibited List 41
WADA Symposium for Anti-Doping Organisations 41
Institute of National Anti-Doping Organisations (iNADO) 42
International Anti-Doping Arrangement (IADA) 42
Monitoring Group for the Council of Europe 42
International conference on the Pharmaceutical Industry and the Fight Against Doping —
New Partnerships for Clean Sport 42
Anti-Doping Norway symposium 42
Regional Anti-Doping Organisations (RADO) 43
International visitors 43
Detection 44
National testing and sport operations program 44
Pure Performance programs 45
User-pays tests 45
Long-term storage facility 46
Accreditation of DCOs and Chaperones 46
Investigations and Intelligence 47
Athlete whereabouts 50
Enforcement 51
Athlete counselling service 53
Chapter 3: Management and accountability 55
Corporate governance 56
Corporate and operational planning 56
Organisational structure and senior executive arrangements 56
Governance committees 57
Risk management 58
Ethical standards 60
Internal audits 61
Records management 61
Quality management 61
External scrutiny 63
Significant developments 63
Decisions and reports 63
Management of human resources 64
Workforce planning 64
Attraction and retention 64
Employment agreements 65
Section 24(1) determinations 65
Non-salary benefits 65
Performance pay 65
Australia Day medallion 65
Survey 66
Learning and development 66
Workplace diversity 67
Commonwealth Disability Strategy 67
Workplace health and safety 67
Chapter 4: Financial information 69
Summary of financial performance 2012–13 70
Asset management 70
Purchasing 71
Engagement of consultants and contractors 71
Consultants 71
Competitive tendering and contracting 72
Auditor-General access 72
Exempt contracts 72
Grant programs 72
Chapter 5: Financial statements 75
Chapter 6: ASADA Advisory Group 127
Overview 128
Advisory Group members 128
Resources 129
Chapter 7: Anti‑Doping Rule Violation Panel 131
Overview 132
Functions 132
Members 132
Resources 134
Chapter 8: Australian Sports Drug Medical Advisory Committee 137
Overview 138
Functions 138
Therapeutic approvals for prohibited substances 139
Members 139
Resources 142
Therapeutic Use Exemptions granted 142
Freedom of information — ASDMAC 145
Chapter 9: Appendixes 147
Appendix A: Doping control statistics 2001–02 to 2012–13 148
Appendix B: Publicly announced anti-doping rule violations 2012–13 149
Appendix C: International anti-doping and doping control 151
Appendix D: Powers of the Minister to give directions to the ASADA CEO 152
Appendix E: ASADA and CEO functions, powers and delegations 153
Appendix F: Staffing statistics at 30 June 2013 154
Appendix G: Workplace health and safety 156
Appendix H: Advertising and market research 157
Appendix I: Ecologically sustainable development and environmental performance 158
Appendix J: Freedom of information 159
Appendix K: Expenses for Outcome 1 160
Appendix L: ASADA Resource Statement 2012–13 161
Chapter 10: Abbreviations and glossary 163
List of abbreviations 164
Glossary 166
Chapter 11: Indexes 171
Compliance index 172
Alphabetical index 176
LIST OF FIGURES
Figure 1: Australia’s anti-doping framework 19
Figure 2: Outcome and program structure 2012–13 21
Figure 3: Number of athletes and support personnel recording anti-doping rule violations 52
Figure 4: Organisational structure at 30 June 2013 57
LIST OF TABLES
Table 1: Program 1.1 qualitative deliverables 26
Table 2: Program 1.1 quantitative deliverables 27
Table 3: Program 1.1 qualitative key performance indicators 28
Table 4: Program 1.1 quantitative key performance indicators 29
Table 5: Education activities undertaken during 2012–13 37
Table 6: Satisfaction with ASADA education 39
Table 7: Anti-doping tests conducted by ASADA in 2012–13 46
Table 8: Doping control facts and figures 2012–13 47
Table 9: Substances involved in anti-doping matters 2012–13 51
Table 10: Breakdown of anti-doping rule violations 2012–13 52
Table 11: Expenditure on new and existing consultancy contracts 2012–13 71
Table 12: Trends in Consultancies 72
Table 13: Advisory Group attendance 2012–13 129
Table 14: Advisory Group expenses 2012–13 129
Table 15: ADRVP attendance 2012–13 133
Table 16: ADRVP expenses 2012–13 134
Table 17: ASDMAC members 141
Table 18: ASDMAC expenses 2012–13 142
Table 19: Therapeutic use exemptions granted 142
Table 20: Substances and methods approved for therapeutic use 2012–13 144
Table 21: ASDMAC freedom of information statistics 145
Table 22: Doping control statistics 148
Table 23: Publicly announced anti-doping rule violations 149
Table 24: Entries on Register of Findings 2011–12 where the outcomes were to be advised 150
Table 25: Government-to-government arrangements 151
Table 26: Full-time, part-time and casual staff at 30 June 2013 154
Table 27: Ongoing, non-ongoing and casual staff by classification groups and location at 30 June 2013 154
Table 28: SES staff at 30 June 2013 154
Table 29: Salary ranges of employees 155
Table 30: Number of staff in the collective agreement or section 24(1) determinations 155
Table 31: Advertising and market research 157
Table 32: ASADA freedom of information statistics 159
Table 33: Expenses for Outcome 1 160
Table 34: ASADA Resource Statement 2012–13 161
